On Monday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) opened higher 6.94% from the last session, before settling in for the closing price of $7.35. Price fluctuations for CRVS have ranged from $2.54 to $10.00 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 8.47% annually for the last half of the decade. Company’s average yearly earnings per share was noted 62.04% at the time writing. With a float of $54.39 million, this company’s outstanding shares have now reached $74.51 million.
Corvus Pharmaceuticals Inc (CRVS) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Corvus Pharmaceuticals Inc is 27.01%, while institutional ownership is 36.95%. The most recent insider transaction that took place on Jun 27 ’25, was worth 4,891,894. In this transaction Director of this company sold 1,176,332 shares at a rate of $4.16, taking the stock ownership to the 7,165,006 shares. Before that another transaction happened on Jun 27 ’25, when Company’s Director sold 1,176,332 for $4.16, making the entire transaction worth $4,891,894. This insider now owns 7,165,006 shares in total.
Corvus Pharmaceuticals Inc (CRVS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.6 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.12) by -0.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.29% during the next five years compared to 8.47% growth over the previous five years of trading.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Trading Performance Indicators
Check out the current performance indicators for Corvus Pharmaceuticals Inc (CRVS). In the past quarter, the stock posted a quick ratio of 8.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Corvus Pharmaceuticals Inc (CRVS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.89 million. That was better than the volume of 0.81 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 55.27%.
During the past 100 days, Corvus Pharmaceuticals Inc’s (CRVS) raw stochastic average was set at 97.29%, which indicates a significant increase from 92.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.56 in the past 14 days, which was higher than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.42, while its 200-day Moving Average is $4.72. However, in the short run, Corvus Pharmaceuticals Inc’s stock first resistance to watch stands at $8.08. Second resistance stands at $8.30. The third major resistance level sits at $8.64. If the price goes on to break the first support level at $7.52, it is likely to go to the next support level at $7.18. Assuming the price breaks the second support level, the third support level stands at $6.96.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Key Stats
There are currently 74,514K shares outstanding in the company with a market cap of 585.68 million. Presently, the company’s annual sales total 0 K according to its annual income of -62,290 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -8,000 K.
